Skip to main content
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. — Investor Relations & Filings

Ticker · NDRA ISIN · US29273B1044 LEI · 6488380RAKK4NN716I68 US Manufacturing
Filings indexed 506 across all filing types
Latest filing 2021-04-29 Regulatory Filings
Country US United States of America
Listing US NDRA

About ENDRA Life Sciences Inc.

https://www.endrainc.com/

ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. The company's core technology is the Thermo-Acoustic Enhanced UltraSound (TAEUS®) platform, designed to enable clinicians to visualize tissue composition and function. The initial application of TAEUS is focused on the early detection and monitoring of liver disease by quantifying fat in the liver. This addresses the clinical need for assessing Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), which are often difficult to diagnose in their early stages. The TAEUS system aims to provide a safe, non-invasive, and cost-effective diagnostic tool that can be used at the point of patient care, offering an alternative to more expensive and less accessible imaging methods.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2021
Regulatory Filings
2021-04-29 English
DEFA14A
Regulatory Filings
2021-04-29 English
DEF 14A
Proxy Solicitation & Information Statement
2021-04-29 English
CURRENT REPORT
Regulatory Filings
2021-04-27 English
FORM 4 SUBMISSION
Director's Dealing
2021-04-07 English
FORM 4 SUBMISSION
Director's Dealing
2021-04-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.